📰 Genentech News
Page 183 - Genentech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Genentech. Real-time updates on events, politics, business and more.
April 6, 2023
Alzheimer's patients who take Leqembi retain the benefits of the treatment even when they stop taking it, new research by Eisai and Biogen shows.
April 6, 2023
Alzheimer’s patients who take Leqembi retain the benefits of the treatment even when they stop taking it, new research by Eisai and Biogen shows.
April 6, 2023
Clinicians discuss the risks and benefits and forecast the use of lecanemab for the treatment of AD in real-world clinical settings.
April 6, 2023
Stephanie L. Graff, MD, gives an overview of recently approved ADCs in TNBC and HR-positive, HER2-negative breast cancer, as well as the importance of continued research with these agents in the first-line setting.
April 6, 2023
Alzheimer's patients who take Leqembi retain the benefits of the treatment even when they stop taking it, new research by Eisai and Biogen shows.
April 5, 2023
On a recent day at Sea Bowl, three generations of the Dockery-Daly family happily rolled frames. Grandma Victoria, daughter Lisa and grandchildren Dominic and Cassie cheered each strike and mourned
April 5, 2023
AC Immune to Host Key Opinion Leader Webinar on Early Diagnosis and Prevention of Alzheimer's Disease Webinar to take place on Tuesday, April 18, 2023, at 10:30 AM EDT / 4:30 PM CEST Lausanne
April 5, 2023
/PRNewswire/ -- GATC Health Corp, a technology company transforming drug discovery and disease prediction using proprietary, disruptive artificial intelligence...
April 5, 2023
Precision fermentation is enjoying a moment. It’s even been hailed as the future of sustainable food, but what actually is it?
April 5, 2023
/PRNewswire/ -- Accord BioPharma, the U.S. specialty division of Intas Pharmaceuticals, Ltd., focused on development of oncology, immunology, and critical care...